Armistice Capital is a global, long/short, value-oriented and event-driven hedge fund focused primarily on the health care and consumer sectors. We invest predominantly in equities and can be opportunistic across the capital structure. We seek to maximize the opportunity set of investment candidates allowing for the selection of unique, concentrated bets to generate uncorrelated returns. We maintain significant position and portfolio level hedges in an effort to mitigate basis and market risks. We view our strategy as the marriage of value and event and aim to produce compelling risk-adjusted returns in all markets.
Steven Boyd, Chief Investment Officer, founded Armistice Capital in 2012. Steven was the first analyst at Senator Investment Group in 2008, joining the firm with its founders from York Capital.
Armistice was the winner of 2017 US Hedge Fund Performance Awards by HFM for long/short equity, long/short equity long-term performance (5 years) under $1bn, and single manager long-term performance under $1bn.*
Steven Boyd, CIO
Steven Boyd is the Founder and Managing Partner of Armistice. Prior to Armistice, Steven was a Senior Research Analyst at Senator Investment Group since pre-launch (February 2008). Before Senator, he was an Associate at York Capital, focusing primarily on investments in consumer and health care equities. Prior to York, Steven worked as an Analyst at SAB Capital Management, a value-oriented long/short equity hedge fund. Steven began his career as an Analyst at McKinsey & Company. He received a B.S. in Economics (with a concentration in Finance) as well as a B.A. in Political Science from The Wharton School of the University of Pennsylvania.
Vivian Wang, Analyst
Vivian Wang is a Consumer Analyst at Armistice. Prior to Armistice, Vivian was a Senior Investment Associate at Bridgewater Associates. Previously, Vivian was an Investment Analyst at Teng Yue Partners, a long/short equity hedge fund, where she was primarily responsible for covering companies in the technology, media and telecom sector. Vivian held the role as an Investment Banking Analyst at Credit Suisse before joining Teng Yue Partners. She received a B. A. in Economics from Princeton University, and an MBA from Harvard Business School.
Charles Shi, Analyst
Charles Shi is a Biotech Analyst at Armistice. Prior to joining, Charles was an Analyst at OrbiMed Advisors where he focused on therapeutics and specialized in catalyst driven investing including clinical trials and FDA decisions. Previously, Charles was an Equity Research Associate at UBS focused on US large and mid-cap biotech. He received a Ph.D in Immunology from Cornell University, and a B.S. in Biotechnology from Sun Yat-sen University.
George Schultz, Analyst
George Schultz is a Consumer Analyst at Armistice. Before Armistice, George was an Analyst at Nitorum Capital, a long/short equity hedge fund. Prior to Nitorum, he was an Analyst at Kenmare Management and Angelo Gordon & Company. George began his career as an Equity Research Associate at Fidelity Management & Research Company. He received a B.A. in Economics from Bowdoin College and an MBA from The Wharton School of the University of Pennsylvania. George is a CFA charterholder.
Joe Sinopoli, Analyst
Joe Sinopoli is a Consumer Analyst at Armistice. Prior to joining Armistice, Joe was an Analyst at Citadel where he managed a retail focused portfolio carve-out. Previously, Joe was an Analyst at Samlyn Capital and Tiger Consumer Management, where he was responsible for covering companies in the consumer discretionary and technology, media & telecom sectors. Joe began his career as an Investment Banking Analyst in the technology, media & telecom group at Deutsche Bank. He received a B.S. from the Dyson School of Applied Economics & Management at Cornell University.
Sergio Smiriglio, Head of Trading
Sergio Smiriglio manages trading operations at Armistice. Previously, Sergio was a Director of Trading at Tourbillon Capital Partners where he was responsible for trade execution and securities financing globally. He was also tasked with the build out of Tourbillon’s execution and portfolio management framework. Prior to Tourbillon, Sergio was with Dialectic Capital Management where he held the position of Co-Head of Risk and Trading - primarily responsible for managing risk and execution globally for the firm. Sergio began his career at Goldman Sachs where he worked in the prime brokerage equity long/short coverage group. He graduated from Steven Institute of Technology with a Bachelor of Engineering in Bio-medical Engineering.
Renato Baba, Investment Engineer
Renato Baba is an investment and data engineer at Armistice. Prior to Armistice, Renato was a Director of Investments at Brasif Group, one of the largest family-owned investment firms in Brazil, performing financial modeling and data driven PE business optimizations. Previously, Renato held Investment Analyst and Associate Portfolio Management roles at hedge funds in Brazil, having begun his career as an Analyst at Value Partners Management Consulting. Renato received a BEng in Mechatronics Engineering from University of Sao Paulo, and an MS in Management from Stanford Graduate School of Business. He is a CFA Charterholder.
Brooke Kilgallen, Head of Business Development
Brooke Kilgallen manages Marketing and Investor Relations at Armistice. Prior to Armistice, Brooke was a Vice President at Goldman Sachs where she most recently spent her time covering hedge funds, asset managers, family offices, and other institutions across all asset classes. Previously, Brooke held a role covering hedge funds for U.S. and International equity sales. Brooke graduated from James Madison University with a Bachelor of Business Administration in Finance and Economics. She is a CFA Charterholder.
Anthony Cordone, Chief Financial Officer
Anthony Cordone manages the firm’s financial and operational activities. Before Armistice, Anthony was the CFO of MM Capital, a volatility arbitrage fund. From 2004-2009, he was COO/CFO/CCO of Litmus Capital Management, a value-oriented hedge fund based in New York. At both MM and Litmus, Anthony was the first CFO and at Litmus, he built the necessary infrastructure to support launch and SEC registration. Previously, Anthony was Controller of ESL Investments in Greenwich, CT. At ESL, Anthony was responsible for the day-to-day operations, controls, and financial records of the $8 billion investment partnership. He began his career at BDO Seidman and ING Alternative Asset Management. Anthony graduated from Fordham University with a Bachelor of Business Administration in Accounting.
Daniel Radden, General Counsel and Chief Compliance Officer
Daniel Radden is the General Counsel and Chief Compliance Officer at Armistice. Prior to Armistice, Daniel was the General Counsel and Chief Compliance Officer of White Elm Capital, LLC, a long/short equity hedge fund. Before joining White Elm, Daniel served as Vice President, Associate Counsel at the Permal Group. Previously, he was an Associate in the Financial Services Group at Katten Muchin Rosenman LLP and was also an Analyst at JPMorgan Chase. Daniel received a B.S. from Cornell University and a J.D. from Fordham University School of Law. Daniel is admitted to practice in New York.
*Neither Armistice nor its employees paid a fee to HFMWeek, an unaffiliated third party, to be considered for the above detailed award(s). It should be noted that the aforementioned accolades should not be unduly relied upon and are not an indication of future performance.